Tricistronic and tetracistronic retroviral vectors for gene transfer

Human Gene Therapy

Volumn 11, Issue 13, 2000, Pages 1921-1931

  De Felipe, P ^a   Izquierdo, M ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ARTICLE; CISTRON; ENCEPHALOMYOCARDITIS VIRUS; FOOT AND MOUTH DISEASE VIRUS; GENE EXPRESSION; GENE INSERTION; GENE SEQUENCE; GENE TRANSFER; GENETIC ENGINEERING; MURINE LEUKEMIA VIRUS; NONHUMAN; PLASMID;

3T3 CELLS; ANIMALS; APHTHOVIRUS; CLONE CELLS; ENCEPHALOMYOCARDITIS VIRUS; GENE EXPRESSION REGULATION, VIRAL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; MICE; REGULATORY SEQUENCES, NUCLEIC ACID; RETICULOENDOTHELIOSIS VIRUS; RETROVIRIDAE; RIBOSOMES;

EID: 0034284152     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050129530     Document Type: Article

References (54)

1. Internal initiation of translation in retroviral vectors carrying picornavirus 5' nontranslated regions
2. Overexpression of DNA polymerase β sensitizes mammalian cells to 2',3'-deoxycytidine and 3'-azido-3'-deoxythymidine
3. Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes
4. Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: Sustained antitumor immunity prolongs animal survival
5. Transcriptional interference in avian retroviruses-implications for the promoter insertion model of leukaemogenesis
6. Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy
7. - Vectors: Murine leukemia virus-based self-inactivating and self-activating retroviral vectors
8. The cleavage activities of aphthovirus and cardiovirus 2A proteins
9. High mutation rate of a spleen necrosis virus-based retrovirus vector
10. High-frequency deletion in recovered retrovirus vector containing endogenous DNA with promoters
11. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism
12. Quantitative analysis of gene suppression in retrovirus vectors
13. Comparison of promoter suppression in avian and murine retrovirus vectors
14. Expression of a multidrug resistance-adenosine deaminase fusion gene
15. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos
16. Translation of encephalomyocarditis virus RNA by internal ribosomal entry
17. Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulable suppression of the v-myc oncogene
18. Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracycline-responsive expression system
19. Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system
20. Gene therapy in brain tumours: Implication of the size of glioblastoma on its curability
21. A comparative view of initiation site selection mechanisms
22. - vectors: Development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy
23. New positive/negative selectable markers for mammalian cells on the basis of Blasticidin deaminase-thymidine kinase fusions
24. A new set of positive/negative selectable markers for mammalian cells
25. Translational efficiency of polycistronic mRNAs and their utilization to express heterologous genes in mammalian cells
26. Effects of intercistronic length on the efficiency of reinitiation by eucaryotic ribosomes
27. The scanning model for translation: An update
28. Characterization of an internal ribosomal entry segment within the 5' leader of avian reticuloendothelioisis virus type A RNA and development of novel MLV-REV-based retroviral vectors
29. Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene
30. Construction and characterization of single-transcript tricistronic retroviral vectors using two internal ribosome entry sites
31. Insertion of several different DNAs in reticuloendotheliosis virus strain T suppresses transformation by reducing the amount of subgenomic mRNA
32. Improved retroviral vectors for gene transfer and expression
33. Retroviral vector containing putative internal ribosome entry sites: Development of a poly-cistronic gene transfer system and applications to human gene therapy
34. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line
35. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-α and herpes simplex virus thymidine kinase
36. Gene therapy against an experimental glioma using adeno-associated virus vectors
37. Stably transmitted triple-promoter retroviral vectors and their use in transformation of primary mammalian cells
38. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cicle: Substitutions, frameshifts, and hypermutations
39. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells
40. Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer
41. Characterization of large deletions occurring during a single round of retrovirus vector replication: Novel deletion mechanism involving errors in strand transfer
42. Inestability of large direct repeats in retrovirus vectors
43. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity
44. Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein
45. Virus-encoded proteinases of the picornavirus super-group
46. A model for nonstoichiometric, cotranslational protein scission in eukaryotic ribosomes
47. Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells
48. Antitumor effects of interleukin-12 (IL-12): Applications for the immunotherapy and gene therapy of cancer
49. Effective eradication of established murine tumors with IL-12 tene therapy using a polycistronic retroviral vector
50. Alternative translation initiation of the Moloney murine leukemia virus mRNA controlled by internal ribosome entry involving the p57/PTB splicing factor
51. Development of a VSV-G protein pseudotyped retroviral vector system expressing dominant oncogenes from a lacO-modified inducible LTR promoter
52. Controlled gene expression with a reverse tetra-cycline-regulated retroviral vector (RTRV) system
53. Construction and characterization of retroviral vectors expressing biologically active human interleukin-12